Completed PHASE3 INTERVENTIONAL 2-arm NCT02755922

Bone Regeneration With Mesenchymal Stem Cells

Bone Regeneration in Mandibular Fractures After the Application of Autologous Mesenchymal Stem Cells. Randomized Clinical Trial.

Sponsor: Instituto Mexicano del Seguro Social

Conditions Mandibular Fractures

Interventions Application of autologous mesenchymal stem cells

Updated 5 times since 2017 Last updated: Apr 26, 2016 Started: Apr 30, 2010 Primary completion: Sep 30, 2010 Completion: Dec 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02755922, this PHASE3 trial focuses on Mandibular Fractures and remains completed. Sponsored by Instituto Mexicano del Seguro Social, it has been updated 5 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Apr 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto Mexicano del Seguro Social

Data source: Instituto Mexicano del Seguro Social

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.